SH3YL1

SH3YL1 is a SYLF/SH3 domain-containing phosphoinositide-binding scaffold protein that couples to NADPH oxidase signaling, small-GTPase-driven migration, and nuclear receptor transcriptional programs (PMID:33086058, PMID:24508479, PMID:26305679). In renal tubular epithelial cells, its SYLF and SH3 domains assemble a ternary complex with Nox4 and p22phox that is required for LPS-triggered H2O2 generation and pro-inflammatory cytokine expression; loss of SH3YL1 protects mice from LPS-induced acute kidney injury, reducing macrophage infiltration and tubular damage (PMID:33086058). Through its phosphoinositide-binding domain SH3YL1 engages the C-terminal proline-rich region of Dock4 to potentiate Dock4-mediated Rac1 activation and cancer cell migration (PMID:24508479). It additionally acts as an androgen receptor coregulator, binding the AR N-terminal polyproline domain to support androgen-dependent gene expression, proliferation, and migration in prostate cancer cells (PMID:26305679). The protein was originally identified in mouse skin as a hair-cycle-regulated transcript localized to the hair bulb and root sheaths (PMID:10771491), but its role in hair biology has not been mechanistically connected to its later-defined molecular activities in the available corpus.

1. 2000 Medium

   Established SH3YL1 as a distinct gene product by identifying a novel mouse protein bearing a C-terminal SH3 domain homologous to yeast Ysc84, and tied its expression to a defined physiological program.

   Evidence Differential cDNA screening, northern blot, and in situ hybridization across the hair-growth cycle in mouse skin

   PMID:10771491

   Open questions at the time

   • No functional intervention linking the protein to hair biology
   • Molecular activity of the SH3 domain not tested
   • No binding partners identified
2. 2014 Medium

   Defined a molecular function for SH3YL1 in cell migration by showing it is a phosphoinositide-binding partner of Dock4 that amplifies Rac1 activation.

   Evidence Co-IP with domain-mutation mapping, Rac1 pull-down activity assay, and siRNA knockdown migration assays in MDA-MB-231 breast cancer cells

   PMID:24508479

   Open questions at the time

   • Specific phosphoinositide species bound not resolved
   • Single-lab evidence without reciprocal in vivo validation
   • Whether membrane recruitment is the rate-limiting step is unclear
3. 2015 Medium

   Extended SH3YL1's role into transcriptional regulation by identifying it as an androgen receptor coregulator acting through the AR polyproline domain.

   Evidence T7 phage display, Co-IP, siRNA knockdown, RNA expression analysis, and proliferation/migration assays in prostate cancer cells

   PMID:26305679

   Open questions at the time

   • Mechanism by which SH3YL1 modulates AR transcriptional output unknown
   • Direct vs scaffold-mediated AR binding not distinguished
   • Single-lab finding
4. 2020 High

   Provided the strongest mechanistic and in vivo evidence by defining SH3YL1 as an obligate assembly factor for Nox4/p22phox-driven ROS production in inflammation.

   Evidence Reciprocal Co-IP of the SH3YL1-Nox4-p22phox ternary complex, domain deletion mapping, and SH3YL1 knockout mice in an LPS-induced acute kidney injury model with H2O2, cytokine, and histological readouts

   PMID:33086058

   Open questions at the time

   • Structural basis of ternary complex assembly not resolved
   • Whether SH3YL1 regulates other Nox isoforms untested
   • Relationship between Nox4 scaffolding and the Dock4/AR roles unexplored

• How SH3YL1's distinct activities — Nox4/p22phox scaffolding, Dock4/Rac1 migration signaling, and AR coregulation — are integrated or context-selected within a single cell remains unresolved.
• No structural model of the SYLF or SH3 domains in complex
• No unified study examining all three functions in one system
• Lipid-binding selectivity and its role in partner choice undefined